The leadership changes arrive as BioNTech reported a 57% rise in net losses for 2025.

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the fourth quarter and full year 2025 on Tuesday, March 10, 2026. Additionally, the Company will host a ...

BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on PD-L11/VEGF-A ...

BioNTech SE BNTX shares are down during Tuesday’s premarket session as the company announced plans for its co-founders to ...

Investors are bracing for a pivotal moment for BioNTech SE. The German biotechnology firm is set to release its full-year 2025 financial results on March 10, an ...

By Ludwig Burger and Patricia Weiss FRANKFURT, March 10 (Reuters) - BioNTech's two co-founders and leading executives will leave the COVID-19 vaccine maker by the end of the year to start a new ...